Risk of CA-AKI and M-ALA with metformin continuation before and after coronary angiography and PCI
diabetic patients [
HYPERGLYCEMIA
Based on this evidence, the risk–benefit trade-off for metformin continuation or suspension should be weighted considering the risk of hyperglycemia, M-ALA, and CA-AKI. Metformin represents the first-line therapy for diabetic patients [